x
|
QUARTERLY
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
ACT OF
1934 FOR THE QUARTERLY PERIOD ENDED September
30, 2007
|
|
|
o
|
TRANSITION
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
ACT OF
1934 FOR THE TRANSITION PERIOD FROM ______________ TO
______________
|
Delaware
|
|
0-2236
|
|
33-0565710
|
(State
or other jurisdiction of incorporation)
|
|
(Commission
File No.)
|
|
(IRS
Employer Identification No.)
|
Part
I. Financial Information
|
||||
|
|
|
||
Explanatory
Note
|
1
|
|||
|
|
|
||
Item
1.
|
Financial
Statements
|
2
|
||
|
Consolidated
Balance Sheets - as of September 30, 2007 (unaudited) (restated)
and March
31, 2007
|
2
|
||
|
|
|
||
|
Unaudited
Consolidated Statements of Operations for the six months ended September
30, 2007 (restated) and 2006 and for the period from inception, August
19,
1999 to September 30, 2007 (restated)
|
3
|
||
|
|
|
||
Unaudited
Consolidated Statements of Operations for the three months ended
September
30, 2007 (restated) and September 30, 2006
|
4
|
|||
|
Unaudited
Consolidated Statement of Changes in Shareholders’ Deficit for the period
from inception, August 19, 1999, to September 30, 2007
|
5
|
||
|
|
|
||
|
Unaudited
Consolidated Statements of Cash Flows for the six months ended September
30, 2007 (restated) and 2006 and for the period from inception, August
19,
1999, to September 30, 2007 (restated)
|
6
|
||
|
|
|
||
|
Notes
to the Unaudited Consolidated Financial Statements
|
7
|
||
|
|
|
||
Item
2.
|
Management’s
Discussion and Analysis or Plan of Operation
|
9
|
||
|
|
|
||
Item
3.
|
Controls
and Procedures
|
16
|
||
|
|
|
||
|
|
|||
Part
II. Other Information
|
||||
|
||||
Item
2.
|
Unregistered
Sales of Equity Securities and Use of Proceeds
|
16
|
||
|
|
|
||
Item
6.
|
Exhibits
|
16
|
|
September
30,
2007
|
March
31,
2007
|
|||||
Unaudited
(Restated)
|
Audited
|
||||||
ASSETS
|
|
|
|||||
|
|
|
|||||
Current
assets:
|
|
|
|||||
Cash
and Cash equivalents
|
$
|
429
|
$
|
1,781
|
|||
Due
from affiliate
|
14,123
|
-
|
|||||
Note
receivable, net of impairment allowance of $0 and $10,710
|
-
|
400,000
|
|||||
Deferred
financing costs
|
-
|
11,438
|
|||||
Total
current assets
|
14,552
|
413,219
|
|||||
|
|||||||
Deferred
financing costs, net of amortization of $7,022 and $2,806
|
78,226
|
75,756
|
|||||
Total
assets
|
$
|
92,778
|
$
|
488,975
|
|||
|
|||||||
LIABILITIES
AND SHAREHOLDERS' DEFICIT
|
|||||||
|
|||||||
Current
liabilities:
|
|||||||
Accounts
payable and accrued liabilities
|
$
|
221,194
|
$
|
154,410
|
|||
Derivative
liabilities
|
8,434,122
|
1,396,245
|
|||||
Notes
payable - shareholder
|
19,800
|
35,000
|
|||||
Due
to affiliate
|
-
|
13,078
|
|||||
Total
current liabilities
|
8,675,116
|
1,598,733
|
|||||
C
Callable secured convertible notes payable net of unamortized discount
of
$588,720 and $592,806
|
11,280
|
7,194
|
|||||
Total
liabilities
|
8,686,396
|
1,605,927
|
|||||
Shareholders'
deficit:
|
|||||||
Preferred
shares - $0.001 par value; 1,000,000 authorized, no shares issued
or
outstanding
|
-
|
-
|
|||||
C
Common shares - $0.001 par value; 50,000,000 authorized; 26,548,292
shares
issued and outstanding
|
26,548
|
26,548
|
|||||
Additional
paid - in capital
|
7,080,898
|
7,080,898
|
|||||
Deficit
accumulated during the development stage
|
(15,701,064
|
)
|
(8,224,398
|
)
|
|||
Total
shareholders' deficit
|
(8,593,618
|
)
|
(1,116,952
|
)
|
|||
Total
liabilities and shareholders' deficit
|
$
|
92,778
|
$
|
488,975
|
|
Six
Months Ended
|
Inception
to
|
||||||||
|
September
30,
|
September
30,
|
September
30,
|
|||||||
|
2007
|
2006
|
2007
|
|||||||
(Restated)
|
(Restated)
|
|||||||||
Expenses
|
||||||||||
General
and administrative
|
412,696
|
257,975
|
1,334,930
|
|||||||
Impairment
of note receivable
|
-
|
-
|
10,701
|
|||||||
Total
expenses
|
412,696
|
257,975
|
1,345,631
|
|||||||
Loss
from operations
|
(412,696
|
)
|
(257,975
|
)
|
(1,345,631
|
)
|
||||
|
||||||||||
Other
income (expense)
|
||||||||||
Interest
income
|
-
|
-
|
10,701
|
|||||||
Interest
expense
|
(26,093
|
)
|
(48,760
|
)
|
(52,290
|
)
|
||||
Change
in fair value of derivatives
|
(7,037,877
|
)
|
-
|
(7,834,122
|
)
|
|||||
Total
other income/(expense)
|
(7,063,970
|
)
|
(48,760
|
)
|
(7,875,711
|
)
|
||||
Loss
from continuing operations
|
(7,476,666
|
)
|
(306,735
|
)
|
(9,221,342
|
)
|
||||
Discontinued
operations
|
||||||||||
Loss
from operations of subsidiary
|
-
|
(763,605
|
)
|
(6,778,804
|
)
|
|||||
Gain
on disposal of subsidiary
|
-
|
-
|
299,082
|
|||||||
Loss
from discontinued operations
|
-
|
(763,605
|
)
|
(6,479,722
|
)
|
|||||
Net
loss
|
$
|
(7,476,666
|
)
|
$
|
(1,070,340
|
)
|
$
|
(15,701,064
|
)
|
|
|
||||||||||
Weighted
Average Shares Outstanding - basic and diluted
|
26,548,292
|
24,726,300
|
||||||||
Basic
and diluted loss per share
|
||||||||||
Continuing
Operations
|
$
|
(0.28
|
)
|
$
|
(0.01
|
)
|
||||
Discontinued
Operations
|
$
|
-
|
$
|
(0.03
|
)
|
|||||
Net
Loss
|
$
|
(0.28
|
)
|
$
|
(0.04
|
)
|
|
Three
Months Ended
|
||||||
|
September
30,
|
September
30,
|
|||||
|
2007
|
2006
|
|||||
|
(Restated)
|
|
|||||
|
|
|
|||||
Expenses
|
|||||||
General
and administrative
|
87,067
|
108,624
|
|||||
Impairment
of note receivable
|
-
|
-
|
|||||
Total
expenses
|
87,067
|
108,624
|
|||||
Loss
from operations
|
(87,067
|
)
|
(108,624
|
)
|
|||
Other
income (expenses)
|
|||||||
Interest
income
|
-
|
-
|
|||||
Interest
expense
|
(7,022
|
)
|
(20,985
|
)
|
|||
Change
in fair value of derivatives
|
(6,563,913
|
)
|
-
|
||||
Total
other income (expense)
|
(6,570,935
|
)
|
(20,985
|
)
|
|||
Loss
from continuing operations
|
(6,658,002
|
)
|
(129,609
|
)
|
|||
Discontinued
operations
|
|||||||
Loss
from operations of subsidiary
|
-
|
(507,194
|
)
|
||||
Gain
on disposal of subsidiary
|
-
|
-
|
|||||
Loss
from discontinued operations
|
-
|
(507,194
|
)
|
||||
Net
loss
|
$
|
(6,658,002
|
)
|
$
|
(636,803
|
)
|
|
Weighted
Average Shares Outstanding - basic and diluted
|
26,548,292
|
24,838,907
|
|||||
Basic
and diluted loss per share
|
|||||||
Continuing
Operations
|
(0.25
|
)
|
(0.01
|
)
|
|||
Discontinued
Operations
|
-
|
(0.02
|
)
|
||||
Net
Loss
|
$
|
(0.25
|
)
|
$
|
(0.03
|
)
|
|
|
|
Additional
|
During the
|
Losses
|
|||||||||||
|
Common Stock
|
Paid-In
|
Development
|
Accumulated
|
||||||||||||
|
Shares
|
Amount
|
Capital
|
Stage
|
Total
|
|||||||||||
|
|
|
|
|
|
|||||||||||
Balance
at March 31, 2007
|
26,548,292
|
$
|
26,548
|
$
|
7,080,898
|
$
|
(8,224,398
|
)
|
$
|
(1,116,952
|
)
|
|||||
Net
loss (Unaudited)
|
-
|
-
|
-
|
(818,664
|
)
|
(818,664
|
)
|
|||||||||
Balance
at June 30, 2007 (Unaudited)
|
26,548,292
|
26,548
|
7,080,898
|
(9,043,062
|
)
|
(1,935,616
|
)
|
|||||||||
Net
loss (Unaudited)
|
-
|
-
|
-
|
(6,658,002
|
)
|
(6,658,002
|
)
|
|||||||||
Balance
at September 30, 2007 (Unaudited)
|
26,548,292
|
$
|
26,548
|
$
|
7,080,898
|
$
|
(15,701,064
|
)
|
$
|
(8,593,618
|
)
|
|
Six
Months Ended
|
Inception
to
|
||||||||
|
September
30,
|
September
30,
|
September
30,
|
|||||||
|
2007
|
2006
|
2007
|
|||||||
|
(Restated)
|
|
(Restated)
|
|||||||
Cash
Flows from Operating Activities:
|
|
|
|
|||||||
Net
loss
|
$
|
(7,476,666
|
)
|
$
|
(1,070,340
|
)
|
$
|
(15,701,064
|
)
|
|
Loss
on discontinued operations
|
-
|
-
|
6,479,722
|
|||||||
Loss
from continuing operations
|
(7,476,666
|
)
|
(1,070,340
|
)
|
(9,221,342
|
)
|
||||
Adjustments
to reconcile net loss to net cash used in operating
activities:
|
||||||||||
Depreciation
|
-
|
2,094
|
-
|
|||||||
Accrued
interest converted to equity
|
-
|
33,439
|
-
|
|||||||
Impairment
of loan receivable
|
-
|
-
|
10,701
|
|||||||
Expenses
paid by shareholder and affiliate
|
515,000
|
|||||||||
Stock
issued for services
|
-
|
250,000
|
692,650
|
|||||||
Amortization
of deferred financing costs
|
8,968
|
-
|
18,796
|
|||||||
Accretion
of discount on convertible notes
|
4,086
|
-
|
-
|
|||||||
Change
in fair value of derivatives
|
7,037,877
|
-
|
7,834,122
|
|||||||
Changes
in
|
||||||||||
Accounts
payable and accrued liabilities
|
66,784
|
41,629
|
221,192
|
|||||||
Due
to affiliate
|
(27,201
|
)
|
-
|
(14,123
|
)
|
|||||
Interest
receivable
|
-
|
(1,093
|
)
|
(10,701
|
)
|
|||||
Deferred
revenue
|
-
|
2,712
|
-
|
|||||||
Net
cash used in operating activities
|
(386,152
|
)
|
(226,559
|
)
|
(464,447
|
)
|
||||
Cash
Flows from Investing Activities
|
||||||||||
Purchase
of property and equipment
|
-
|
(2,030
|
)
|
-
|
||||||
Loan
receivable
|
-
|
(100,000
|
)
|
-
|
||||||
Investment
in note receivable
|
-
|
-
|
(400,000
|
)
|
||||||
Proceeds
from note receivable
|
400,000
|
-
|
400,000
|
|||||||
Net
cash provided by (used in) investing activities
|
400,000
|
(102,030
|
)
|
-
|
||||||
Cash
Flows from Financing Activities
|
||||||||||
Proceeds
from issuance of common stock
|
-
|
24,695
|
24,695
|
|||||||
Proceeds
from notes payable - shareholder / affiliate
|
19,800
|
254,700
|
54,800
|
|||||||
Proceeds
from convertible notes payable
|
-
|
-
|
600,000
|
|||||||
Payments
on notes payable - shareholder
|
(35,000
|
)
|
(2,181
|
)
|
(35,000
|
)
|
||||
Debt
issuance costs
|
-
|
(5,000
|
)
|
(90,000
|
)
|
|||||
Net
cash provided by (used in) financing activities
|
(15,200
|
)
|
272,214
|
554,495
|
||||||
Discontinued
operations
|
||||||||||
Discontinued
operating activities
|
-
|
-
|
(4,506,211
|
)
|
||||||
Discontinued
investing activities
|
-
|
-
|
(187,748
|
)
|
||||||
Discontinued
financing activities
|
-
|
-
|
4,604,340
|
|||||||
Net
cash provided by (used in) discontinued operations
|
-
|
-
|
(89,619
|
)
|
||||||
Net
increase (decrease) in cash and cash equivalents
|
(1,352
|
)
|
(56,375
|
)
|
429
|
|||||
|
||||||||||
Cash
and cash equivalents
|
||||||||||
Beginning
of period - continuing operations
|
1,781
|
62,383
|
-
|
|||||||
Beginning
of period - discontinued operations
|
-
|
-
|
-
|
|||||||
End
of period - continuing operations
|
$
|
429
|
$
|
6,008
|
$
|
429
|
||||
End
of period - discontinued operations
|
$
|
-
|
$
|
-
|
$
|
-
|
Previously
Reported
|
|
Adjustments
|
|
As
Restated
|
||||||
Assets
- DR(CR)
|
99,768
|
(6,990
|
)
|
92,778
|
||||||
Liabilities
- DR
(CR)
|
(2,035,384
|
)
|
(6,651,012
|
)
|
(8,686,396
|
)
|
||||
YTD
Net Loss
|
(818,664
|
)
|
(6,658,002
|
)
|
(7,476,666
|
)
|
||||
Loss
Per Share
|
(0.03
|
)
|
(0.25
|
)
|
(0.28
|
)
|
|
·
|
intentional
manipulation of the price of the Common Stock by existing or future
stockholders;
|
|
·
|
short
selling of the Common Stock or related derivative
securities;
|
|
·
|
a
single acquisition or disposition, or several related acquisitions
or
dispositions, of a large number of shares of Common
Stock;
|
|
·
|
the
interest, or lack of interest, of the market in the Company’s business
sector, without regard to the Company’s financial condition or results of
operations;
|
|
·
|
the
adoption of governmental regulations and similar developments in
the
United States or abroad that may affect the Company’s ability to offer the
Company’s products and services or affect the Company’s cost structure;
|
|
·
|
developments
in the businesses of companies that purchase the Company’s products;
and
|
|
·
|
economic
and other external market factors, such as a general decline in market
prices due to poor economic indicators or investor
distrust.
|
|
·
|
Is
priced under five dollars;
|
|
·
|
Is
not traded on a national stock exchange, the Nasdaq Global Market
or the
Nasdaq Capital Market;
|
|
·
|
Is
issued by a company that has less than $5 million in net tangible
assets
(if it has been in business less than three years) or has less than
$2
million in net tangible assets (if it has been in business for at
least
three years); and
|
|
·
|
Is
issued by a company that has average revenues of less than $6 million
for
the past three years.
|
|
·
|
Certain
broker-dealers who recommend penny stock to persons other than established
customers and accredited investors must make a special written suitability
determination for the purchaser and receive the purchaser’s written
agreement to a transaction prior to sale.
|
|
·
|
Prior
to executing any transaction involving a penny stock, certain
broker-dealers must deliver to certain purchasers a disclosure schedule
explaining the risks involved in owning penny stock, the broker-dealer’s
duties to the customer, a toll-free telephone number for inquiries
about
the broker-dealer’s disciplinary history and the customer’s rights and
remedies in case of fraud or abuse in the
sale.
|
|
·
|
In
connection with the execution of any transaction involving a penny
stock,
certain broker-dealers must deliver to certain purchasers the following:
|
|
|
·
bid and offer price quotes and volume
information;
|
|
|
·
the broker-dealer’s compensation for the
trade;
|
|
|
·
the compensation received by certain salespersons for the
trade;
|
|
|
·
monthly accounts statements;
and
|
|
|
· A
written statement of the customer’s financial situation and investment
goals.
|
SKRM
Interactive, Inc.
|
||
|
|
|
Date
March 3, 2008
|
By: | /s/ Pericles DeAvila |
|
Pericles
DeAvila, President
|
Date
March 3, 2008
|
By: | /s/ Pericles DeAvila |
|
Pericles DeAvila |
|
Chief
Financial Officer
|
EXHIBIT
INDEX
|
Exhibit
No.
|
|
Exhibit
|
|
Incorporated
by Reference/ Filed Herewith
|
|
|
|
|
|
31.1
|
|
Rule
13a-14(a)/15d-14(a) Certification of Chief Executive
Officer
|
|
Filed
herewith
|
|
|
|
|
|
31.2
|
|
Rule
13a-14(a)/15d-14(a) Certification of Chief Financial
Officer
|
|
Filed
herewith
|
|
|
|
|
|
32.1
|
|
Section
1350 Certification of Chief Executive Officer
|
|
Filed
herewith
|
|
|
|
|
|
32.2
|
|
Section
1350 Certification of Chief Financial Officer
|
|
Filed
herewith
|